Best Apps for Diabetics on Ozempic, Mounjaro, or Trulicity

GLP-1 medications were originally developed for type 2 diabetes, and the cardiovascular and metabolic benefits in diabetic patients are dramatic. Average HbA1c reductions of 1.5 to 2.0 points. Often-substantial weight loss as a side benefit. Cardiovascular risk reduction.

A diabetic patient on Ozempic, Mounjaro, or Trulicity has more variables to track than a non-diabetic weight loss patient. Glucose patterns, HbA1c trends, hypoglycemia risk if on insulin, and the same protein and muscle preservation concerns that apply to everyone on these medications.

This guide covers what to look for in an app and the focused tool we recommend.

What diabetic patients on GLP-1 should track

Six priorities:

1. Weight trend. Weekly, with goal-weight calibration for protein targets.

2. Glucose patterns. Fasting glucose, post-meal spikes, overnight drift if on a CGM.

3. HbA1c every 3 to 6 months. The lab number that tracks long-term control.

4. Insulin or sulfonylurea dose adjustments. Often need to come down on a GLP-1.

5. Protein floor. Same as non-diabetics: 0.7 to 1.0 g per pound of goal weight.

6. Resistance training. Skeletal muscle is the largest glucose disposal tissue. More muscle equals better insulin sensitivity, independent of weight.

The recommended app: Sharpy

Sharpy is built around the GLP-1 reality, including diabetic users:

• Goal-weight protein calibrated for muscle preservation
• Lifting programs that build the glucose-disposing muscle that compounds the GLP-1 metabolic effect
• Side effect log for the patterns that matter on tirzepatide and semaglutide
• Weekly weight trends instead of daily noise
• Hydration and electrolyte tracking, important for diabetic kidney health

What Sharpy does not do directly:

• CGM integration (currently)
• Insulin dosing recommendations (this is medical territory)
• HbA1c lab integration

For these, pair Sharpy with your existing diabetes management tool or CGM app.

Get Sharpy on the App Store. Free to download.

A typical day for a diabetic on a GLP-1

Consider you are on Mounjaro 7.5 mg with type 2 diabetes:

• Morning: Check fasting glucose; log weight (weekly). Greek yogurt + whey + berries (32 g protein). 16 oz water with electrolytes.
• Mid-morning: 15-minute walk after breakfast (helps post-meal glucose).
• Lunch: Chicken bowl with rice and vegetables (30 g protein). 10-minute walk after.
• Afternoon: Protein shake (25 g protein).
• Dinner: Salmon with potato and spinach (30 g protein). 10-minute walk after.
• Pre-bed: Magnesium glycinate. 7+ hour sleep target.
• 3x per week: 35-minute lifting session.

Sharpy tracks the protein, lifting, hydration, and weight pieces. Glucose-specific tracking sits in your CGM app or whatever you use for that.

Cardiovascular and kidney benefits

Diabetic patients on GLP-1 medications often see broader benefits beyond glucose:

• Cardiovascular event reduction (SUSTAIN-6, LEADER, REWIND trials)
• Kidney function preservation (FLOW trial in CKD)
• Liver fat reduction for fatty liver disease
• Lower blood pressure
• Improved lipid profile

The lifestyle inputs (Sharpy tracks these) compound the medication's metabolic benefits.

What other apps miss

Most diabetes apps focus on glucose data and miss the muscle preservation angle. Most weight loss apps focus on calories and miss the diabetes context. The right combination for diabetic GLP-1 patients is usually:

• Sharpy for protein, lifting, side effects, and the GLP-1 daily structure
• A CGM app or diabetes manager for glucose patterns
• Periodic lab reviews with your endocrinologist for HbA1c trends

Bottom line

Diabetic patients on Ozempic, Mounjaro, or Trulicity benefit from a focused GLP-1 app paired with their existing diabetes tools. Sharpy handles the protein, lifting, side effects, and weight pieces. Pair it with your CGM or diabetes manager for glucose. Download Sharpy on the App Store. Free.